Investing.comCodex · 实盘不做把握 8/10
北京时间·🕒 发布 08-03 18:36:39时区推断·⟳ 抓取 08-03 18:37:24·⚡ 决策 08-04 08:18:33 +13h41m·84.7 天前
KKR拟以每股127美元现金收购Integer Holdings，企业价值约57亿美元
Integer股东将获得每股127美元现金，对4月29日收盘价溢价约51.8%、对7月31日30日VWAP溢价约28.8%。
📄 原文Investing.com↗ 原文
KKR to acquire Integer Holdings for $127 per share in cash
Oil falls over 4% as Trump calls off Iran strike, announces fresh talks PLANO, Texas and NEW YORK - Integer Holdings Co…
不做 Integer Holdings（ITGR.US）
现金收购利好已基本兑现，现价124.45美元距127美元仅约2.0%，剩余并购套利价差过薄。
不做 KKR（KKR.US）
57亿美元收购对KKR约957亿美元市值不构成短线市值级增量，且买方并购不适合追多。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-03 06:36 ET · 扩散 high · price-in 风险 high ↗
消息传播链
- 公司此前宣布战略评估，为后续出售预期提供背景。
- 披露KKR关联基金拟以每股127美元现金收购Integer，企业价值约57亿美元。市场反应:ITGR.US公告日收于124.45美元。
- 2026-08-04 00:13 UTC市场反应stock_quote非一手ITGR.US最新价124.45美元，前收121.21美元，当日涨2.67%，距127美元现金价仅约2.0%。市场反应:交易收益主要已兑现为并购套利价差。
关键理由
- Integer股东将获得每股127美元现金，对4月29日收盘价溢价约51.8%、对7月31日30日VWAP溢价约28.8%。
- 交易企业价值约57亿美元，董事会已一致批准，且不以融资为条件。
- 但ITGR.US最新价124.45美元，距离127美元现金对价仅约2.0%，且7月31日已大涨20.18%、8月3日再涨2.67%，并购溢价已基本兑现。
主要风险
- 交易仍需股东批准和监管审批，预计年底前完成；当前2%左右毛价差不足以覆盖事件交易风险。
- KKR市值约957亿美元，57亿美元收购对其短线损益弹性有限。
反向证据
- 做多前查反向 · 来源 stock_quote · 日期 2026-08-04 · 影响 weakens
ITGR.US已接近127美元现金对价，剩余约2.0%毛价差不足以覆盖等待到年底和审批风险。
检索:Integer Holdings KKR 127 cash deal spread current price 124.45 approval regulatory risk - 做多前查反向 · 来源 stock_quote · 日期 2026-08-04 · 影响 weakens
KKR约957亿美元市值，57亿美元收购对买方短线财务弹性不够大。
检索:KKR acquire Integer Holdings 5.7B impact KKR market cap
工具调用 · 历史记录,结果未知(3 种)
- search_processed_events · 结果未知
- stock_quote · 结果未知
- normalize_ticker · 结果未知
原文全文
展开原文 · 2,554 字
Oil falls over 4% as Trump calls off Iran strike, announces fresh talks
PLANO, Texas and NEW YORK - Integer Holdings Corporation (NYSE:ITGR) announced today that it has entered into a definitive agreement to be acquired by an affiliate of investment funds managed by KKR in an all-cash transaction valued at approximately $5.7 billion in enterprise value.
Under the terms of the agreement, Integer stockholders will receive $127 per share in cash. The price represents a premium of approximately 51.8% to Integer’s closing share price on April 29, 2026, the day before the company announced a strategic review, and 28.8% to the 30-day volume-weighted average price as of July 31, 2026, according to a press release statement.
The transaction follows a comprehensive strategic review announced by Integer on April 30, 2026. The Integer Board of Directors has unanimously approved the agreement and recommends that stockholders vote to approve the transaction and adopt the merger agreement.
Integer is a medical device contract development and manufacturing organization serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. The company operates a global manufacturing footprint and employs approximately 11,000 associates.
"This is an exciting milestone for Integer and a testament to the dedication and commitment of our talented team and the exceptional business we have built together," said Payman Khales, Integer’s President and CEO.
Max Lin, Partner at KKR, stated that Integer is "an exceptional platform with highly differentiated capabilities across a global manufacturing footprint, a track record for quality and reliability, and a talented team operating in attractive, durable end-markets."
KKR intends to establish a broad-based employee ownership and engagement program at Integer following the close of the transaction. The transaction is not subject to any financing contingency. KKR will finance the transaction through a combination of equity provided by investment funds managed by KKR and committed debt financing.
The transaction is expected to close by the end of the year, subject to approval by Integer stockholders and required regulatory approvals. Upon completion, Integer will become a privately held company and its common stock will no longer be listed on the New York Stock Exchange.
Integer has withdrawn its previously issued financial outlook given the pending transaction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
PLANO, Texas and NEW YORK - Integer Holdings Corporation (NYSE:ITGR) announced today that it has entered into a definitive agreement to be acquired by an affiliate of investment funds managed by KKR in an all-cash transaction valued at approximately $5.7 billion in enterprise value.
Under the terms of the agreement, Integer stockholders will receive $127 per share in cash. The price represents a premium of approximately 51.8% to Integer’s closing share price on April 29, 2026, the day before the company announced a strategic review, and 28.8% to the 30-day volume-weighted average price as of July 31, 2026, according to a press release statement.
The transaction follows a comprehensive strategic review announced by Integer on April 30, 2026. The Integer Board of Directors has unanimously approved the agreement and recommends that stockholders vote to approve the transaction and adopt the merger agreement.
Integer is a medical device contract development and manufacturing organization serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. The company operates a global manufacturing footprint and employs approximately 11,000 associates.
"This is an exciting milestone for Integer and a testament to the dedication and commitment of our talented team and the exceptional business we have built together," said Payman Khales, Integer’s President and CEO.
Max Lin, Partner at KKR, stated that Integer is "an exceptional platform with highly differentiated capabilities across a global manufacturing footprint, a track record for quality and reliability, and a talented team operating in attractive, durable end-markets."
KKR intends to establish a broad-based employee ownership and engagement program at Integer following the close of the transaction. The transaction is not subject to any financing contingency. KKR will finance the transaction through a combination of equity provided by investment funds managed by KKR and committed debt financing.
The transaction is expected to close by the end of the year, subject to approval by Integer stockholders and required regulatory approvals. Upon completion, Integer will become a privately held company and its common stock will no longer be listed on the New York Stock Exchange.
Integer has withdrawn its previously issued financial outlook given the pending transaction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。